Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Topiramate

An antiepileptic discovered in 1979 by researchers Bruce Maryanoff and Joseph Gardocki and first approved as an anticonvulsant in 1996: it is used for several types of epileptic seizure and also to prevent migraine. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It has an unusual structure for an antiepileptic, a fructose-like sugar carrying a sulfamate group: it was born in a diabetes project, and its anticonvulsant effect emerged by chance in early tests.

TopiramateGo to the active ingredient →
TopiramateActive ingredientTopiramateCat. No. P-T162-001CAS 97240-79-4
Topiramate-d12Isotopically labelledTopiramate-d12Cat. No. P-T162-006CAS 1279037-95-4

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substanceTopiramate CRSEDQM code Y0002134Family Topiramate

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.